Data obtained from cell cultures and animal models suggest that adiponectin inhibits leptin-induced proliferation of HCC via blocking downstream pathways including STAT-3, AKT and mammalian target of rapamycin (m-TOR) [51]. The gene discussed is ADIPOQ; the disease is hepatocellular carcinoma.